长期抗凝治疗患者的凝血因子分析
Coagulation factor analysis in patients on long-term anticoagulation.
作者信息
Perkins H A, Biben R L
出版信息
Calif Med. 1970 Mar;112(3):1-7.
Abstract
Ninety studies on 58 patients undergoing chronic warfarin therapy included Quick prothrombin times, partial thromboplastin times, thromboplastin generation tests and assays for clotting factors II, V, VII, VIII, IX, X, XI and XII. The results indicate no benefit from supplementation of the Quick tests by any of these other procedures. It is suggested that the Quick test uniformly performed, using a standard uniform thromboplastin, would be the procedure of choice.
摘要
对58例接受慢性华法林治疗的患者进行了90项研究，包括测定凝血酶原时间、部分凝血活酶时间、凝血活酶生成试验以及凝血因子II、V、VII、VIII、IX、X、XI和XII的检测。结果表明，这些其他检测方法对补充凝血酶原时间检测并无益处。建议采用标准统一的凝血活酶，统一进行凝血酶原时间检测，这将是首选的检测方法。
相似文献
1
Coagulation factor analysis in patients on long-term anticoagulation.长期抗凝治疗患者的凝血因子分析
Calif Med. 1970 Mar;112(3):1-7.
2
Reappraisal of thromboplastin.凝血活酶的重新评估
Ann Clin Lab Sci. 1981 May-Jun;11(3):202-10.
3
Hypoperfusion in severely injured trauma patients is associated with reduced coagulation factor activity.严重创伤患者的低灌注与凝血因子活性降低有关。
J Trauma. 2011 Nov;71(5 Suppl 1):S435-40. doi: 10.1097/TA.0b013e318232e5cb.
4
Effects of preeclampsia on maternal and cord blood clotting activity.子痫前期对母体和脐带血凝血活性的影响。
Am J Perinatol. 1985 Oct;2(4):279-82. doi: 10.1055/s-2007-999970.
5
[Evaluation of an automatic clot-sensing instrument : Coag A Pet 200 (author's transl)].[自动凝血传感仪器的评估：Coag A Pet 200（作者译）]
Nouv Rev Fr Hematol (1978). 1978 Jun 10;20(2):199-208.
6
Clotting changes in borderline hypertension.临界高血压的凝血变化
J Hum Hypertens. 1987 Sep;1(2):101-3.
7
Significantly different coagulation factor activities underlying the variability of 'normal' activated partial thromboplastin time.“正常”活化部分凝血活酶时间变异性背后存在显著不同的凝血因子活性。
Blood Coagul Fibrinolysis. 2012 Jan;23(1):35-8. doi: 10.1097/MBC.0b013e32834a6136.
8
[Evaluation of the KC10 semi-automatic modular clot detection device].[KC10半自动模块化凝血检测设备的评估]
Nouv Rev Fr Hematol (1978). 1983;25(2):113-21.
9
Coagulation, fibrinolysis, and kinin generation in adult cats.成年猫的凝血、纤维蛋白溶解和激肽生成
Am J Vet Res. 1982 Aug;43(8):1478-80.
10
In vitro evaluation of residual procoagulants in human intravenous immunoglobulins from 11 Chinese blood fractionation companies.在中国 11 家血液制品公司生产的人静脉注射用免疫球蛋白中残留促凝血因子的体外评估
Thromb Res. 2013 Sep;132(3):381-5. doi: 10.1016/j.thromres.2013.07.020. Epub 2013 Jul 31.
引用本文的文献
1
Differences in the INR evaluation of two different thromboplastins in patients with positivity to lupus anticoagulant in ongoing oral anticoagulation.正在接受口服抗凝治疗且狼疮抗凝物阳性患者中，两种不同凝血活酶的国际标准化比值（INR）评估差异。
J Blood Med. 2010;1:57-60. doi: 10.2147/JBM.S8938. Epub 2010 May 3.
本文引用的文献
1
A comparison of laboratory methods for the control of anticoagulant therapy with prothrombinopenic agents. I. The Quick one-stage procedure, the prothrombin and proconvertin test and the one-stage determination of true prothrombin activity.
Am J Med. 1961 Oct;31:547-54. doi: 10.1016/0002-9343(61)90138-3.
2
Relation between levels of plasma thromboplastin component (PTC) and prothrombin times by the P&P and Quick methods in patients receiving warfarin.接受华法林治疗患者血浆凝血活酶成分（PTC）水平与采用P&P法和Quick法测定的凝血酶原时间之间的关系。
N Engl J Med. 1962 Jul 19;267:125-30. doi: 10.1056/NEJM196207192670303.
3
Bleeding from occult tumors during anticoagulant therapy.
Circulation. 1962 May;25:804-6. doi: 10.1161/01.cir.25.5.804.
4
A simple assay method for factor X (Stuart-Prower factor).一种检测因子X（斯图尔特-普罗沃因子）的简单方法。
Proc Soc Exp Biol Med. 1962 Mar;109:754-6. doi: 10.3181/00379727-109-27328.
5
Thrombotest. A new method for controlling anticoagulant therapy.凝血试验。一种控制抗凝治疗的新方法。
Lancet. 1959 Nov 7;2(7106):754-8. doi: 10.1016/s0140-6736(59)90857-8.
6
THE INTERACTION OF CONTACT PRODUCT AND FACTOR IX.接触产物与凝血因子IX的相互作用
Thromb Diath Haemorrh. 1964 Apr 15;11:155-66.
7
8
A new assay for factor V (proaccelerin-accelerin) using Russell's viper venom.一种使用罗素蝰蛇毒的凝血因子V（前加速素-加速素）新检测法。
J Lab Clin Med. 1960 Apr;55:625-32.
9
A simple, specific one-stage assay for plasma thromboplastin antecedent activity.一种用于检测血浆促凝血酶原激酶前体活性的简单、特异性单阶段检测方法。
J Lab Clin Med. 1961 May;57:771-80.
10
Levels of blood-coagulation factors during anticoagulant therapy with phenindione.使用苯茚二酮进行抗凝治疗期间的血液凝固因子水平。
Br Med J. 1961 Apr 29;1(5234):1205-10. doi: 10.1136/bmj.1.5234.1205.
Zotero 插件